RadNet (RDNT) Competitors

Fulgent Genetics (NASDAQ:FLGT) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Do analysts recommend FLGT or RDNT?

Fulgent Genetics currently has a consensus price target of $28.50, indicating a potential upside of 64.64%. RadNet has a consensus price target of $74.75, indicating a potential downside of 6.07%. Given Fulgent Genetics' higher possible upside, analysts plainly believe Fulgent Genetics is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fulgent Genetics	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
RadNet	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Does the media favor FLGT or RDNT?

In the previous week, RadNet had 1 more articles in the media than Fulgent Genetics. MarketBeat recorded 14 mentions for RadNet and 13 mentions for Fulgent Genetics. RadNet's average media sentiment score of 0.82 beat Fulgent Genetics' score of 0.39 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fulgent Genetics	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
RadNet	4 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in FLGT or RDNT?

48.1% of Fulgent Genetics shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 31.8% of Fulgent Genetics shares are held by insiders. Comparatively, 5.1% of RadNet shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has more risk and volatility, FLGT or RDNT?

Fulgent Genetics has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500.

Does the MarketBeat Community prefer FLGT or RDNT?

RadNet received 103 more outperform votes than Fulgent Genetics when rated by MarketBeat users. Likewise, 65.84% of users gave RadNet an outperform vote while only 60.40% of users gave Fulgent Genetics an outperform vote.

Company	Underperform	Outperform
Fulgent Genetics	Outperform Votes 244 60.40%	Underperform Votes 160 39.60%
RadNet	Outperform Votes 347 65.84%	Underperform Votes 180 34.16%

Which has better earnings and valuation, FLGT or RDNT?

RadNet has higher revenue and earnings than Fulgent Genetics. RadNet is trading at a lower price-to-earnings ratio than Fulgent Genetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fulgent Genetics	$289.21M	1.83	-$167.82M	-$5.52	-3.14
RadNet	$1.77B	3.32	$3.04M	-$0.07	-1,136.86

Is FLGT or RDNT more profitable?

RadNet has a net margin of -0.25% compared to Fulgent Genetics' net margin of -59.39%. RadNet's return on equity of 4.29% beat Fulgent Genetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fulgent Genetics	-59.39%	-1.81%	-1.66%
RadNet	-0.25%	4.29%	1.45%

Summary

RadNet beats Fulgent Genetics on 16 of the 19 factors compared between the two stocks.